Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Decrease in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totaling 295 shares, a drop of 61.7% from the April 30th total of 770 shares. Based on an average daily volume of 64,427 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC raised its stake in shares of Fidelity Disruptive Medicine ETF by 4.6% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock worth $19,712,000 after purchasing an additional 31,629 shares during the last quarter. Virtu Financial LLC purchased a new position in shares of Fidelity Disruptive Medicine ETF in the fourth quarter worth about $228,000. Vise Technologies Inc. purchased a new position in shares of Fidelity Disruptive Medicine ETF in the fourth quarter worth about $234,000. Jane Street Group LLC raised its stake in shares of Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock worth $2,473,000 after purchasing an additional 44,630 shares during the last quarter. Finally, Glass Jacobson Investment Advisors llc raised its stake in shares of Fidelity Disruptive Medicine ETF by 44.0% in the fourth quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock worth $34,000 after purchasing an additional 385 shares during the last quarter.

Fidelity Disruptive Medicine ETF Stock Down 0.4%

Shares of NASDAQ:FMED opened at $25.17 on Friday. Fidelity Disruptive Medicine ETF has a 52-week low of $22.80 and a 52-week high of $29.07. The stock has a market cap of $57.89 million, a price-to-earnings ratio of 41.33 and a beta of 0.84. The business has a 50-day moving average price of $24.84 and a 200-day moving average price of $26.17.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.